Filing Details
- Accession Number:
- 0001596783-24-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-30 16:45:41
- Reporting Period:
- 2024-07-26
- Accepted Time:
- 2024-07-30 16:45:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1596783 | Catalent Inc. | CTLT | Pharmaceutical Preparations (2834) | 208737688 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1862832 | Ricky Hopson | C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 | Pres. Bioproduct Delivery, Cos | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-07-26 | 10,225 | $0.00 | 30,842 | No | 4 | A | Direct | |
Common Stock | Disposition | 2024-07-29 | 206 | $58.67 | 30,636 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Restricted stock units (RSUs) received by the reporting person pursuant to the Issuers annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuers common stock as of the date of vesting, which will occur in three equal annual installments beginning on July 26, 2025.
- Includes RSUs.
- Shares sold by the reporting person through an automatic sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuers omnibus incentive plan. No shares were withheld by or surrendered to the Issuer.
- Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $58.64 to $58.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.